In the News
November 17, 2023 | Duke Research Blog
Gersbach among those on Clarivate's Most Highly Cited Scientists for 2023
Gerbach is one of the most highly cited authors in Biology & Biochemistry
November 9, 2023 | Pratt School of Engineering
Master Regulator of the Dark Genome Greatly Improves Cancer T-Cell Therapy
A CRISPR-based platform identified many genes that could potentially improve T-cell therapies for cancer treatment
November 2, 2023
CAGT Travel Award Winners: Mia Hamilton & Lauren Hong
The Center for Advanced Genomic Technologies (CAGT) awarded two travel awards to current trainees. These awards will help trainees seek external opportunities to extend the scope and impact of their research by learning new methods or technologies and bring that expertise [...]
October 16, 2023 | Duke School of Medicine
Surprise Discovery Reveals Key Factor in Multiple Sclerosis
Researchers at Duke University School of Medicine studying multiple sclerosis made an unexpected discovery that could reshape the understanding of MS treatments.
October 2, 2023 | Duke School of Medicine
Using Gene Therapy to Treat Brain Disease
Doug Marchuk and Aravind Asokan have been awarded a three-year $1.9 million grant from the Department of Defense to develop less invasive treatment options for familial cerebral cavernous malformations (CCM).
July 20, 2023 | Cision PR Newswire
CRISPR/Gene Editing Technology Creates New Treatment Possibilities for Alzheimer's Disease
Boris Kantor and Ornit Chiba-Falek described an epigenome therapy platform based on CRISPR/dCas9-editing strategy intended to reduce APOE-e4 at the Alzheimer's Association International Conference
July 10, 2023
CAGT Dedicating to Mentoring
The genomics field at Duke is thriving because of the highly collaborative, interdisciplinary research environment that spans basic, translational, and clinical research. Mentoring future researchers is a key priority at the center. CAGT faculty are committed to training, [...]
June 29, 2023 | Duke School of Medicine
Muscle Stem Cells: Should I Stay or Should I Go?
Our bodies have the remarkable ability to heal from these injuries, thanks to muscle stem cells.
April 26, 2023
Cameron Kim wins Klein Family Distinguished Teaching Award
Klein Family Distinguished Teaching Award Cameron Kim, PhD Recognizes an outstanding educator. These faculty inspire students to learn and apply knowledge, engage students in the classroom and share their love of engineering. Cameron is passionate about training the next [...]
April 25, 2023
Cameron Kim Wins Bass Connections Leadership Award
March 30, 2023 | Duke School of Medicine
Collaboration Seeks Genetic Clues to Chronic Lung Disease
Idiopathic pulmonary fibrosis (IPF) is a disease that causes scarring on the lungs. Over time, as more scarring occurs, patients experience decreased lung function and difficulty breathing. Once diagnosed, most patients die within five years.
March 30, 2023 | Duke School of Medicine
Study Reveals How UV Radiation May Drive Melanoma
Raluca Gordân, PhD, and team investigated how transcription factors may affect the production of genetic mutations, or mutagenesis, by binding to the wrong sites after being exposed to ultraviolet (UV) radiation.
March 27, 2023 | Duke Today
Alumnus Ariel Kantor Cited by Forbes Europe in 30 Under 30 List
Duke alumnus, former member of the Gersbach lab, and Rhodes Scholar Ariel Kantor was selected for Forbes Europe's latest "30 under 30" — an annual listing of top young innovators, entrepreneurs and world changers.
February 1, 2023 | Duke OTC
Asokan named Global Scholar
December 15, 2022 | Duke Today
Gersbach Elected to National Academy of Inventors
December 13, 2022 | Duke Today
Gene Therapy for Heart Attacks in Mice Just Got More Precise
A team of Duke scientists studying how other animals regrow damaged tissues has made an important step toward controlling at least one part of the regenerative machinery with that kind of precision.
November 30, 2022 | Duke School of Medicine
Aravind Asokan to Lead Partnership with Danaher Corporation to Accelerate Gene Therapy Breakthroughs
Aravind Asokan will lead a new strategic partnership with Danaher Corporation to form the first Danaher Beacon for Gene Therapy Innovation, a new initiative designed to access breakthrough science to create technologies and applications that will improve human health.
November 16, 2022 | Duke Research Blog
Gersbach Among Most Cited Scientists
Gersbach is one of 30 Duke faculty to make this year's list
November 11, 2022 | Cision PR Newswire
Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation
Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation.
October 13, 2022 | WRAL TechWire
Kris Wood startup Tavros Therapeutics strikes $430M deal with Bayer subsidiary
The oncology startup Tavros Therapeutics has signed a five-year collaboration with Vividion Therapeutics that could bring as much as $430.5 million to the RTP firm.
October 5, 2022 | Duke Today
New RNA-based Tool Can Illuminate Brain Circuits, Edit Specific Cells
Editing technology is precise and broadly applicable to all tissues and animal species
October 4, 2022 | Duke CTSI
Duke Kannapolis Director Outlines Future at North Carolina Research Campus
Svati H. Shah, MD, MHS, spoke to partners at the North Carolina Research Campus (NCRC) about the pivotal role of Duke Kannapolis at the 350-acre translational science hub focused on human health and nutrition.
September 6, 2022
Anoop Patel joins Duke, CAGT
We are excited to welcome Anoop Patel, MD, associate professor of neurosurgery, to the CAGT community. Patel graduated magna cum laude from Harvard Medical School and completed residency as well as a research fellowship at Massachusetts General Hospital. He comes to Duke [...]